Peer-reviewed article
The introduction of innovative technology into practice
Stories of clinical innovation in medicine are generally stories of fits and starts, of irrational exuberance and of avoidable tragedy, of skill, luck, science, and serendipity. Such stories are often transformed, in retrospect, into…
Stories of clinical innovation in medicine are generally stories of fits and starts, of irrational exuberance and of avoidable tragedy, of skill, luck, science, and serendipity. Such stories are often transformed, in retrospect, into orderly, semi-fictional narratives that show science as a rational process. These narratives portray medical progress as the result of carefully designed experiments that test specific hypotheses. The results of such experiments, so the story goes, are then incorporated into clinical practice. The real history of innovation is both more fun and more frightening than such myths might suggest.
Related writing.
Why the Dutch Keep Pediatric Euthanasia Illegal
Pediatric euthanasia in The Netherlands has a unique legal status - it is illegal, openly practiced, and well-regulated. The most surprising part isn't the law that enabled this — it's what happened after.
Associations of Physician Perspectives, Personal Choices, and Counseling for Severe Congenital Heart Defects
OBJECTIVE: To assess whether physicians' perspectives of outcomes or personal choices are associated with prenatal counseling for termination of pregnancy (TOP) or perinatal hospice for severe congenital heart defects (CHDs). METHOD:…
Variation in the extent to which patient information leaflets describe potential benefits and harms of trial interventions: a commentary
Clinical trial participants must understand the possible risks and benefits of trial interventions before providing their informed consent to participate. The aim of this commentary is twofold: to summarize the discrepancies in the extent…
Pediatric Gender Medicine—Reply
Third, emerging evidence suggests that modulating glycosylation pathways could offer a novel therapeutic strategy for asthma management.Xie et al 5 proposed that targeting glycan recognition receptors, such as sialic acid-binding…
About the author
John D. Lantos is a pediatrician and bioethicist writing on AI in medicine, neonatal intensive care, and end-of-life decisions. His essays appear in JAMA, JAMA Pediatrics, the Hastings Center Report, the New England Journal of Medicine, and Aeon. Read more about John.